BioSpace News Archive

Drug Development

Sirtex Medical Release: Randomized Controlled Trial of Radioactive Resin Microspheres Demonstrates Significant Delay in Progression of Disease in Patients with Colorectal Cancer Liver Metastases who have Exhausted Chemotherapy

June 1, 2009
·
1 min read
Drug Development

BioLineRx Ltd. Announces Positive Preliminary Results From the Phase I/II Trial of BL-1040, the First Injectable Device Addressing Pathological Cardiac Remodeling

June 1, 2009
·
1 min read
BioCapital

Cylex, Inc.: Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients

June 1, 2009
·
3 min read
Drug Development

AEterna Zentaris Partner Keryx Biopharmaceuticals Reports Positive Phase 2 Data for Perifosine (KRX-0401) in Colon and Kidney Cancer at American Society of Clinical Oncology Meeting

June 1, 2009
·
3 min read
Drug Development

Millennium: The Takeda Oncology Company: In Clinical Trials VELCADE(R) (Bortezomib) for Injection as a Foundation of Therapy Continues to Deliver Significant Response Rates in Previously Untreated Multiple Myeloma Patients

June 1, 2009
·
1 min read
Policy

Nabi Biopharmaceuticals Announces Withdrawal of Biotest Pharmaceuticals’s Indemnification Claim

June 1, 2009
·
1 min read
Genetown

Concert Pharmaceuticals, Inc. to Participate in the Private Company Forum at the 30th Annual Goldman Sachs Global Healthcare Conference

June 1, 2009
·
1 min read
Drug Development

Threshold Pharmaceuticals, Inc. Presents Encouraging Data From Clinical Trials of TH-302 for Solid Tumors

June 1, 2009
·
1 min read
Biotech Beach

Vical Incorporated to Present At Upcoming Investor Conferences

June 1, 2009
·
1 min read
BioForest

CombiMatrix Featured On CNBC

June 1, 2009
·
1 min read